| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| CMO/CDMO(元) | 26,245,216.64 | 65,201,580.58 | 26,569,288.29 |
| 技术服务(元) | 44,468,204.19 | 62,904,276.20 | 19,966,413.97 |
| 原料药销售(元) | 60,344,728.59 | 121,142,771.61 | 57,356,450.10 |
| 制剂销售(元) | 515,378,861.10 | - | 564,910,164.43 |
| 化学制剂(元) | - | 1,076,693,282.66 | - |
| 其他(元) | 8,011,558.94 | 21,970,029.59 | - |
| 营业成本(元) | |||
| CMO/CDMO(元) | 18,757,925.06 | 56,306,364.59 | 20,236,761.21 |
| 技术服务(元) | 514,060.03 | 11,204,958.78 | 2,953,628.96 |
| 原料药销售(元) | 28,023,995.15 | 48,176,553.66 | 19,921,762.55 |
| 制剂销售(元) | 104,419,965.42 | - | 106,013,060.50 |
| 化学制剂(元) | - | 200,040,034.49 | - |
| 其他(元) | 6,608,726.67 | 20,871,528.07 | - |
| 毛利(元) | |||
| CMO/CDMO(元) | 7,487,291.58 | 8,895,215.99 | 6,332,527.08 |
| 技术服务(元) | 43,954,144.16 | 51,699,317.42 | 17,012,785.01 |
| 原料药销售(元) | 32,320,733.44 | 72,966,217.95 | 37,434,687.55 |
| 制剂销售(元) | 410,958,895.68 | - | 458,897,103.93 |
| 化学制剂(元) | - | 876,653,248.17 | - |
| 其他(元) | 1,402,832.27 | 1,098,501.52 | - |
| 毛利率(%) | |||
| CMO/CDMO(%) | 28.53 | 13.64 | 23.83 |
| 技术服务(%) | 98.84 | 82.19 | 85.21 |
| 原料药销售(%) | 53.56 | 60.23 | 65.27 |
| 制剂销售(%) | 79.74 | - | 81.23 |
| 化学制剂(%) | - | 81.42 | - |
| 其他(%) | 17.51 | 5.00 | - |
| 收入构成(%) | |||
| CMO/CDMO(%) | 4.01 | 4.84 | 3.97 |
| 技术服务(%) | 6.79 | 4.67 | 2.99 |
| 原料药销售(%) | 9.22 | 8.99 | 8.58 |
| 制剂销售(%) | 78.75 | - | 84.47 |
| 化学制剂(%) | - | 79.88 | - |
| 其他(%) | 1.22 | 1.63 | - |
| 毛利构成(%) | |||
| CMO/CDMO(%) | 1.51 | 0.88 | 1.22 |
| 技术服务(%) | 8.86 | 5.11 | 3.27 |
| 原料药销售(%) | 6.51 | 7.22 | 7.20 |
| 制剂销售(%) | 82.83 | - | 88.30 |
| 化学制剂(%) | - | 86.68 | - |
| 其他(%) | 0.28 | 0.11 | - |